Rhabdomyolysis induced by fenofibrate monotherapy
Rhabdomyolysis with fibrate have been reported when fibrate are associated with statin or during renal insufficiency or hypothyroidism. We describe one patient with diabetes mellitus treated by fenofibrate monotherapy since several years; 48 h after gliclazide therapy was introduced, rhabdomyolysis...
Gespeichert in:
| Veröffentlicht in: | La revue de medecine interne 2006-07, Vol.27 (7), p.573 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | 573 |
| container_title | La revue de medecine interne |
| container_volume | 27 |
| creator | Archambeaud-Mouveroux, F Lopez, S Combes, C Lassandre, S Amaniou, M Teissier, M-P Galinat, S |
| description | Rhabdomyolysis with fibrate have been reported when fibrate are associated with statin or during renal insufficiency or hypothyroidism.
We describe one patient with diabetes mellitus treated by fenofibrate monotherapy since several years; 48 h after gliclazide therapy was introduced, rhabdomyolysis occurred.
Responsibilities of deshydratation and / or drug interaction with gliclazide. are discussed. |
| doi_str_mv | 10.1016/j.revmed.2006.02.013 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16716459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16716459</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-91d06120f40d23574692d4ef98c562a58e8fc88a9f4acd8e0301e9feb75311e3</originalsourceid><addsrcrecordid>eNo1j8tqwzAQRbVoSdI0f1CKf8DqjCTL0rKEviBQKNkHyRoRh9gytlPQ3zfQdnU3h8O5jD0gcATUTyc-0ndHgQsAzUFwQHnDViCUKY3WcsnupukEAFfaLtgSdY1aVXbF8OvofEhdTuc8tVPR9uHSUCh8LiL1KbZ-dDMVXerTfKTRDfme3UZ3nmjzt2u2f33Zb9_L3efbx_Z5Vw4o7VxaDKBRQFQQhKxqpa0IiqI1TaWFqwyZ2BjjbFSuCYZAApKN5OtKIpJcs8df7XDx12eHYWw7N-bDf7r8AXOGRe8</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Rhabdomyolysis induced by fenofibrate monotherapy</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Archambeaud-Mouveroux, F ; Lopez, S ; Combes, C ; Lassandre, S ; Amaniou, M ; Teissier, M-P ; Galinat, S</creator><creatorcontrib>Archambeaud-Mouveroux, F ; Lopez, S ; Combes, C ; Lassandre, S ; Amaniou, M ; Teissier, M-P ; Galinat, S</creatorcontrib><description>Rhabdomyolysis with fibrate have been reported when fibrate are associated with statin or during renal insufficiency or hypothyroidism.
We describe one patient with diabetes mellitus treated by fenofibrate monotherapy since several years; 48 h after gliclazide therapy was introduced, rhabdomyolysis occurred.
Responsibilities of deshydratation and / or drug interaction with gliclazide. are discussed.</description><identifier>ISSN: 0248-8663</identifier><identifier>DOI: 10.1016/j.revmed.2006.02.013</identifier><identifier>PMID: 16716459</identifier><language>fre</language><publisher>France</publisher><subject>Diabetes Mellitus - drug therapy ; Drug Interactions ; Dyslipidemias - drug therapy ; Fenofibrate - adverse effects ; Follow-Up Studies ; Gliclazide - adverse effects ; Humans ; Hypoglycemic Agents - adverse effects ; Hypolipidemic Agents - adverse effects ; Male ; Middle Aged ; Rhabdomyolysis - chemically induced</subject><ispartof>La revue de medecine interne, 2006-07, Vol.27 (7), p.573</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16716459$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Archambeaud-Mouveroux, F</creatorcontrib><creatorcontrib>Lopez, S</creatorcontrib><creatorcontrib>Combes, C</creatorcontrib><creatorcontrib>Lassandre, S</creatorcontrib><creatorcontrib>Amaniou, M</creatorcontrib><creatorcontrib>Teissier, M-P</creatorcontrib><creatorcontrib>Galinat, S</creatorcontrib><title>Rhabdomyolysis induced by fenofibrate monotherapy</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>Rhabdomyolysis with fibrate have been reported when fibrate are associated with statin or during renal insufficiency or hypothyroidism.
We describe one patient with diabetes mellitus treated by fenofibrate monotherapy since several years; 48 h after gliclazide therapy was introduced, rhabdomyolysis occurred.
Responsibilities of deshydratation and / or drug interaction with gliclazide. are discussed.</description><subject>Diabetes Mellitus - drug therapy</subject><subject>Drug Interactions</subject><subject>Dyslipidemias - drug therapy</subject><subject>Fenofibrate - adverse effects</subject><subject>Follow-Up Studies</subject><subject>Gliclazide - adverse effects</subject><subject>Humans</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypolipidemic Agents - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Rhabdomyolysis - chemically induced</subject><issn>0248-8663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tqwzAQRbVoSdI0f1CKf8DqjCTL0rKEviBQKNkHyRoRh9gytlPQ3zfQdnU3h8O5jD0gcATUTyc-0ndHgQsAzUFwQHnDViCUKY3WcsnupukEAFfaLtgSdY1aVXbF8OvofEhdTuc8tVPR9uHSUCh8LiL1KbZ-dDMVXerTfKTRDfme3UZ3nmjzt2u2f33Zb9_L3efbx_Z5Vw4o7VxaDKBRQFQQhKxqpa0IiqI1TaWFqwyZ2BjjbFSuCYZAApKN5OtKIpJcs8df7XDx12eHYWw7N-bDf7r8AXOGRe8</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Archambeaud-Mouveroux, F</creator><creator>Lopez, S</creator><creator>Combes, C</creator><creator>Lassandre, S</creator><creator>Amaniou, M</creator><creator>Teissier, M-P</creator><creator>Galinat, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200607</creationdate><title>Rhabdomyolysis induced by fenofibrate monotherapy</title><author>Archambeaud-Mouveroux, F ; Lopez, S ; Combes, C ; Lassandre, S ; Amaniou, M ; Teissier, M-P ; Galinat, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-91d06120f40d23574692d4ef98c562a58e8fc88a9f4acd8e0301e9feb75311e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2006</creationdate><topic>Diabetes Mellitus - drug therapy</topic><topic>Drug Interactions</topic><topic>Dyslipidemias - drug therapy</topic><topic>Fenofibrate - adverse effects</topic><topic>Follow-Up Studies</topic><topic>Gliclazide - adverse effects</topic><topic>Humans</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypolipidemic Agents - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Rhabdomyolysis - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Archambeaud-Mouveroux, F</creatorcontrib><creatorcontrib>Lopez, S</creatorcontrib><creatorcontrib>Combes, C</creatorcontrib><creatorcontrib>Lassandre, S</creatorcontrib><creatorcontrib>Amaniou, M</creatorcontrib><creatorcontrib>Teissier, M-P</creatorcontrib><creatorcontrib>Galinat, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Archambeaud-Mouveroux, F</au><au>Lopez, S</au><au>Combes, C</au><au>Lassandre, S</au><au>Amaniou, M</au><au>Teissier, M-P</au><au>Galinat, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rhabdomyolysis induced by fenofibrate monotherapy</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2006-07</date><risdate>2006</risdate><volume>27</volume><issue>7</issue><spage>573</spage><pages>573-</pages><issn>0248-8663</issn><abstract>Rhabdomyolysis with fibrate have been reported when fibrate are associated with statin or during renal insufficiency or hypothyroidism.
We describe one patient with diabetes mellitus treated by fenofibrate monotherapy since several years; 48 h after gliclazide therapy was introduced, rhabdomyolysis occurred.
Responsibilities of deshydratation and / or drug interaction with gliclazide. are discussed.</abstract><cop>France</cop><pmid>16716459</pmid><doi>10.1016/j.revmed.2006.02.013</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0248-8663 |
| ispartof | La revue de medecine interne, 2006-07, Vol.27 (7), p.573 |
| issn | 0248-8663 |
| language | fre |
| recordid | cdi_pubmed_primary_16716459 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Diabetes Mellitus - drug therapy Drug Interactions Dyslipidemias - drug therapy Fenofibrate - adverse effects Follow-Up Studies Gliclazide - adverse effects Humans Hypoglycemic Agents - adverse effects Hypolipidemic Agents - adverse effects Male Middle Aged Rhabdomyolysis - chemically induced |
| title | Rhabdomyolysis induced by fenofibrate monotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A56%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rhabdomyolysis%20induced%20by%20fenofibrate%20monotherapy&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Archambeaud-Mouveroux,%20F&rft.date=2006-07&rft.volume=27&rft.issue=7&rft.spage=573&rft.pages=573-&rft.issn=0248-8663&rft_id=info:doi/10.1016/j.revmed.2006.02.013&rft_dat=%3Cpubmed%3E16716459%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16716459&rfr_iscdi=true |